The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Comparison of ColoPrint risk classification with clinical risk in the prospective PARSC trial.
Ramon Salazar
No relevant relationships to disclose
Jaume Capdevila
No relevant relationships to disclose
Robert Rosenberg
No relevant relationships to disclose
Jan Willem de Waard
No relevant relationships to disclose
Bengt Glimelius
No relevant relationships to disclose
Frederic Bibeau
No relevant relationships to disclose
Joost Klaase
No relevant relationships to disclose
Jacobus JM Van der Hoeven
No relevant relationships to disclose
Rachel A Midgley
No relevant relationships to disclose
George J. Chang
No relevant relationships to disclose
Thomas Bachleitner-Hofmann
No relevant relationships to disclose
Michio Asano
No relevant relationships to disclose
Reinhard Ziebermayr
No relevant relationships to disclose
Edward Allen Levine
No relevant relationships to disclose
Kenneth B. Deck
No relevant relationships to disclose
Jamie Sington
No relevant relationships to disclose
Wai Lun Law
No relevant relationships to disclose
Imad Shbeeb
No relevant relationships to disclose
Lisette Stork
Employment or Leadership Position - Agendia
John Marshall
No relevant relationships to disclose